Pharmacokinetics of dopamine in critically ill newborn infants
- PMID: 2391608
- DOI: 10.1016/s0022-3476(05)81101-1
Pharmacokinetics of dopamine in critically ill newborn infants
Abstract
Dopamine pharmacokinetics was investigated in 14 critically ill newborn infants ranging from 27 to 43 weeks of gestational age and from 0.9 to greater than 4 kg birth weight. Plasma clearance rate was determined from dopamine levels during controlled infusions under actual clinical conditions. Dopamine was administered in stepwise increasing doses up to 8 micrograms/kg/min. Dopamine concentration and dopamine clearance rate were determined from duplicate samples drawn during each infusion in each patient. Steady-state plasma dopamine concentrations and plasma clearance rates were observed within 20 minutes at each infusion. Plasma dopamine concentration ranged from 0.5 ng/ml before infusion to almost 70 ng/ml at an infusion rate of 4 to 8 micrograms/kg/min. There was a linear correlation between infusion rate and plasma dopamine concentration (r = 0.68, p less than 0.001). Neither plasma dopamine concentration nor infusion rate had a significant effect on clearance rate. These data are consistent with first-order kinetics for administered dopamine in critically ill neonates over the range of concentrations studied.
Similar articles
-
Dopamine pharmacokinetics in critically ill newborn infants.Eur J Clin Pharmacol. 1991;40(6):593-7. doi: 10.1007/BF00279976. Eur J Clin Pharmacol. 1991. PMID: 1884740
-
Dopamine pharmacokinetics in critically ill newborn infants.J Pediatr. 1987 Feb;110(2):293-8. doi: 10.1016/s0022-3476(87)80176-2. J Pediatr. 1987. PMID: 3806305
-
Dopamine clearance in critically ill patients.Intensive Care Med. 1998 Nov;24(11):1217-20. doi: 10.1007/s001340050747. Intensive Care Med. 1998. PMID: 9876986
-
Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children.Crit Care Med. 1997 Jan;25(1):181-9. doi: 10.1097/00003246-199701000-00032. Crit Care Med. 1997. PMID: 8989196 Clinical Trial.
-
Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.Dan Med Bull. 1998 Jun;45(3):282-97. Dan Med Bull. 1998. PMID: 9675540 Review.
Cited by
-
Pharmacokinetics and pharmacodynamics of dopamine and norepinephrine in critically ill head-injured patients.Intensive Care Med. 2004 Jan;30(1):45-50. doi: 10.1007/s00134-003-2032-4. Epub 2003 Oct 29. Intensive Care Med. 2004. PMID: 14586494 Clinical Trial.
-
Pharmacokinetics of drugs used in critically ill adults.Clin Pharmacokinet. 1998 Jan;34(1):25-56. doi: 10.2165/00003088-199834010-00002. Clin Pharmacokinet. 1998. PMID: 9474472 Review.
-
Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients.J Neural Transm (Vienna). 2021 Jul;128(7):1135-1145. doi: 10.1007/s00702-021-02374-4. Epub 2021 Jul 18. J Neural Transm (Vienna). 2021. PMID: 34275001 Free PMC article.
-
Dopamine use is an indicator for the development of threshold retinopathy of prematurity.Br J Ophthalmol. 1999 Apr;83(4):425-8. doi: 10.1136/bjo.83.4.425. Br J Ophthalmol. 1999. PMID: 10434864 Free PMC article.
-
Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia.Cochrane Database Syst Rev. 2002;2002(3):CD003484. doi: 10.1002/14651858.CD003484. Cochrane Database Syst Rev. 2002. PMID: 12137696 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical